Belgaum Diabetic Centre Report issue

Academic/Hospital Phase 1

Organization Overview

First Clinical Trial
2010
NCT01035801
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Alternative names

Belgaum Diabetic Centre, Ground floor,Beside mahila Vastu Bhander, Maruti Gali, Belgaum- 590001

Active Ingredients

Drugs in Phase 1 Trials (2)

insulin human (humulin) (1 trial)

insulin lispro (humalog) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus (Phase 1)

Diabetes Mellitus, Type 1 (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 2